Andrew J. Nicoll
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Reply to: Intrinsic Toxicity of Antibodies to the Globular Domain of the Prion Protein.
Journal: Biological psychiatry
Published: March 29, 2018
G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo.
Journal: EMBO molecular medicine
Published: November 09, 2017
Prion Protein as a Toxic Acceptor of Amyloid-β Oligomers.
Journal: Biological psychiatry
Published: May 31, 2017
Erratum: Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy.
Journal: Nature
Published: September 17, 2015
Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy.
Journal: Nature
Published: April 26, 2015
Identification of a Compound That Disrupts Binding of Amyloid-β to the Prion Protein Using a Novel Fluorescence-based Assay.
Journal: The Journal of biological chemistry
Published: January 13, 2015
C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins.
Journal: Science (New York, N.Y.)
Published: August 09, 2014
N-terminal domain of prion protein directs its oligomeric association.
Journal: The Journal of biological chemistry
Published: July 31, 2014
Peripheral administration of a humanized anti-PrP antibody blocks Alzheimer's disease Aβ synaptotoxicity.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: May 03, 2014
mGlu5 receptors and cellular prion protein mediate amyloid-β-facilitated synaptic long-term depression in vivo.
Journal: Nature communications
Published: October 02, 2013
Last Updated: 09/26/2026